Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema | Zendy

Marco Cicardi | Zendy; Aleena Banerji | Zendy; Francisco Bracho | Zendy; Alejandro Malbrán | Zendy; Bernd Rosenkranz | Zendy; Marc A. Riedl | Zendy; Konrad Bork | Zendy; William Lumry | Zendy; Werner Aberer | Zendy; H. Bier | Zendy; Murat Baş | Zendy; Jens Greve | Zendy; Thomas K. Hoffmann | Zendy; Henriette Farkas | Zendy; Avner Reshef | Zendy; Bruce Ritchie | Zendy; William H. Yang | Zendy; Jürgen Grabbe | Zendy; Shmuel Kivity | Zendy; W. Kreuz | Zendy; Robyn J. Levy | Zendy; Thomas J. Luger | Zendy; Krystyna Obtułowicz | Zendy; Peter SchmidGrendelmeier | Zendy; Christian Bull | Zendy; Brigita Šitkauskienė | Zendy; William Smith | Zendy; Elias Toubi | Zendy; Sonja Werner | Zendy; Suresh Anné | Zendy; Janne Björkander | Zendy; Laurence Bouillet | Zendy; Enrìco Cillari | Zendy; David Hurewitz | Zendy; Kraig W. Jacobson | Zendy; Constance H. Katelaris | Zendy; Marcus Maurer | Zendy; Hans F. Merk | Zendy; Jonathan A. Bernstein | Zendy; Conleth Feighery | Zendy; Bernard Floccard | Zendy; Gerald J. Gleich | Zendy; Jacques Hébert | Zendy; Martin Kaatz | Zendy; Paul K. Keith | Zendy; Charles H. Kirkpatrick | Zendy; David Langton | Zendy; Ludovic Martin | Zendy; Christiane E. Pichler | Zendy; David Resnick | Zendy; Duane G. Wombolt | Zendy; Diego S. Fernández Romero | Zendy; Andrea Zanichelli | Zendy; Francesco Arcoleo | Zendy; Jochen Knolle | Zendy; Irina Kravec | Zendy; Liying Dong | Zendy; Jens Zimmermann | Zendy; Kimberly Rosen | Zendy; Wing Tze Fan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

Author(s) -

Marco Cicardi,

Aleena Banerji,

Francisco Bracho,

Alejandro Malbrán,

Bernd Rosenkranz,

Marc A. Riedl,

Konrad Bork,

William Lumry,

Werner Aberer,

H. Bier,

Murat Baş,

Jens Greve,

Thomas K. Hoffmann,

Henriette Farkas,

Avner Reshef,

Bruce Ritchie,

William H. Yang,

Jürgen Grabbe,

Shmuel Kivity,

W. Kreuz,

Robyn J. Levy,

Thomas J. Luger,

Krystyna Obtułowicz,

Peter SchmidGrendelmeier,

Christian Bull,

Brigita Šitkauskienė,

William Smith,

Elias Toubi,

Sonja Werner,

Suresh Anné,

Janne Björkander,

Laurence Bouillet,

Enrìco Cillari,

David Hurewitz,

Kraig W. Jacobson,

Constance H. Katelaris,

Marcus Maurer,

Hans F. Merk,

Jonathan A. Bernstein,

Conleth Feighery,

Bernard Floccard,

Gerald J. Gleich,

Jacques Hébert,

Martin Kaatz,

Paul K. Keith,

Charles H. Kirkpatrick,

David Langton,

Ludovic Martin,

Christiane E. Pichler,

David Resnick,

Duane G. Wombolt,

Diego S. Fernández Romero,

Andrea Zanichelli,

Francesco Arcoleo,

Jochen Knolle,

Irina Kravec,

Liying Dong,

Jens Zimmermann,

Kimberly Rosen,

Wing Tze Fan

Publication year - 2010

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0906393

Subject(s) - icatibant , bradykinin , hereditary angioedema , angioedema , medicine , antagonist , bradykinin receptor , receptor antagonist , c1 inhibitor , pharmacology , dermatology , receptor

Hereditary angioedema is characterized by recurrent attacks of angioedema of the skin, larynx, and gastrointestinal tract. Bradykinin is the key mediator of symptoms. Icatibant is a selective bradykinin B2 receptor antagonist.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research